Carson Wealth (CWM LLC)’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,390
Closed -$300K 5534
2025
Q2
$300K Buy
6,390
+4,236
+197% +$188K ﹤0.01% 1870
2025
Q1
$95K Buy
2,154
+1,923
+832% +$88.5K ﹤0.01% 2469
2024
Q4
$8K Sell
231
-235
-50% -$8.21K ﹤0.01% 4013
2024
Q3
$15K Sell
466
-328
-41% -$12.3K ﹤0.01% 3559
2024
Q2
$30K Buy
794
+89
+13% +$3.75K ﹤0.01% 2840
2024
Q1
$35K Sell
705
-9
-1% -$416 ﹤0.01% 2547
2023
Q4
$26K Sell
714
-328
-31% -$8.56K ﹤0.01% 2608
2023
Q3
$24K Sell
1,042
-142
-12% -$3.88K ﹤0.01% 2577
2023
Q2
$31K Buy
1,184
+91
+8% +$2.39K ﹤0.01% 2355
2023
Q1
$28K Sell
1,093
-91
-8% -$2.66K ﹤0.01% 2274
2022
Q4
$31K Sell
1,184
-71
-6% -$1.75K ﹤0.01% 2065
2022
Q3
$36K Sell
1,255
-36,713
-97% -$1.05M ﹤0.01% 1836
2022
Q2
$935K Sell
37,968
-5,266
-12% -$193K 0.01% 576
2022
Q1
$2.44M Sell
43,234
-6,039
-12% -$346K 0.02% 378
2021
Q4
$3.05M Buy
+49,273
New +$3.26M 0.02% 359
2021
Q2
$4.45M Hold
53,948
0.04% 293
2021
Q1
$4.45M Hold
53,948
0.04% 293
2020
Q4
$4.45M Hold
53,948
0.04% 293
2020
Q3
$4.45M Hold
53,948
0.04% 293
2020
Q2
$4.45M Hold
53,948
0.04% 293
2020
Q1
$4.45M Hold
53,948
0.04% 293
2019
Q4
$4.45M Hold
53,948
0.04% 293
2019
Q3
$4.45M Buy
+53,948
New +$1.28M 0.04% 293

Other funds holding SWTX

Carson Wealth (CWM LLC)'s SWTX Position: Q3 2025 in Review

Carson Wealth (CWM LLC) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 6,390 shares — an estimated $300K sold.

Carson Wealth (CWM LLC) first reported a position in SWTX in Q3 2019 and held it in 23 quarters. The position peaked at $4.45M in Q2 2021. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Carson Wealth (CWM LLC) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 6,390 SpringWorks Therapeutics shares in Q3 2025, an estimated $300K.
  • Carson Wealth (CWM LLC) first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 23 quarters.
  • Carson Wealth (CWM LLC)'s SpringWorks Therapeutics position peaked at $4.45M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2025, filed 15 Oct 2025.